Yueh-Fu Fang Selected Research

Yueh-Fu Fang Research Topics

Disease

23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 09/2006
14	Neoplasms (Cancer) 01/2024 - 09/2006
11	Adenocarcinoma of Lung 02/2023 - 01/2015
9	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2015
9	Lung Neoplasms (Lung Cancer) 01/2023 - 09/2008
3	Body Weight (Weight, Body) 01/2023 - 11/2017
3	Disease Progression 01/2022 - 03/2021
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 11/2018
2	Diarrhea 01/2022 - 03/2021
2	Brain Neoplasms (Brain Tumor) 01/2018 - 10/2015
2	Bronchiectasis 09/2017 - 01/2013
2	Hypoxia (Hypoxemia) 01/2011 - 07/2010
2	Adenocarcinoma 09/2008 - 09/2006
1	Dermatitis 02/2023
1	Mucositis 02/2023
1	Sarcopenia 01/2023
1	Asthma (Bronchial Asthma) 01/2023
1	Circulating Neoplastic Cells 09/2022
1	Liver Neoplasms (Liver Cancer) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Obstructive Lung Diseases (Obstructive Lung Disease) 10/2021
1	Stroke (Strokes) 10/2021
1	Aortic Dissection 10/2021
1	Drug Eruptions (Drug Eruption) 07/2021
1	Infections 02/2021
1	Pain (Aches) 02/2021
1	Paronychia 02/2021
1	Pneumonia (Pneumonitis) 11/2018
1	Poisoning 11/2018
1	Hypoventilation 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2015
1	Foreign Bodies (Foreign Body) 01/2015
1	Breast Neoplasms (Breast Cancer) 09/2014
1	Triple Negative Breast Neoplasms 09/2014
1	Dyspnea (Shortness of Breath) 01/2014
1	Hemorrhage 01/2014
1	Cystic Fibrosis (Mucoviscidosis) 01/2013
1	Hypotension (Low Blood Pressure) 01/2011
1	Healthcare-Associated Pneumonia 09/2008
1	Delirium 09/2008

Drug/Important Bio-Agent (IBA)

32	ErbB Receptors (EGF Receptor)IBA 01/2024 - 09/2006
20	Tyrosine Kinase InhibitorsIBA 01/2024 - 09/2008
15	AfatinibIBA 01/2023 - 10/2015
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2023 - 10/2015
5	Gefitinib (Iressa)FDA Link 02/2022 - 09/2006
4	osimertinibIBA 01/2024 - 12/2021
4	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2020
2	Oxygen (Dioxygen)IBA 10/2021 - 09/2017
2	Epidermal Growth Factor (EGF)IBA 07/2021 - 11/2017
2	SolutionsIBA 07/2021 - 02/2021
2	Phosphotransferases (Kinase)IBA 06/2013 - 09/2006
1	Methionine (L-Methionine)FDA Link 01/2024
1	Threonine (L-Threonine)FDA Link 01/2024
1	Codon (Codons)IBA 01/2024
1	ZincIBA 02/2023
1	Nuclear Export Signals (Nuclear Export Signal)IBA 01/2023
1	Proline (L-Proline)FDA Link 01/2023
1	Serine (L-Serine)FDA Link 01/2023
1	DNA (Deoxyribonucleic Acid)IBA 09/2022
1	pembrolizumabIBA 02/2022
1	fibrin fragment D (D-dimer)IBA 01/2022
1	CadmiumIBA 10/2021
1	durvalumabIBA 10/2021
1	Dicloxacillin (Dycill)FDA LinkGeneric 07/2021
1	ceritinibIBA 03/2021
1	CrizotinibIBA 03/2021
1	Anaplastic Lymphoma KinaseIBA 03/2021
1	alectinibIBA 03/2021
1	Antineoplastic Agents (Antineoplastics)IBA 02/2021
1	Betaxolol (Kerlon)FDA LinkGeneric 02/2021
1	Fluorine-18IBA 12/2019
1	Cholinergic Agents (Cholinergics)IBA 11/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2018
1	CarbamatesIBA 11/2018
1	OrganophosphatesIBA 11/2018
1	Hypnotics and Sedatives (Sedatives)IBA 01/2017
1	Cetuximab (Erbitux)FDA Link 12/2015
1	Tyrosine (L-Tyrosine)FDA Link 06/2013
1	C-Reactive ProteinIBA 01/2013
1	Pemetrexed (MTA)FDA Link 01/2011
1	Propofol (Diprivan)FDA LinkGeneric 01/2011
1	Docetaxel (Taxotere)FDA Link 01/2011
1	Midazolam (Versed)FDA LinkGeneric 07/2010
1	Alfentanil (Alfenta)FDA LinkGeneric 07/2010

Therapy/Procedure

12	Therapeutics 02/2023 - 01/2011
5	Drug Therapy (Chemotherapy) 01/2024 - 01/2010
2	Artificial Respiration (Mechanical Ventilation) 11/2018 - 09/2008
2	Radiotherapy 01/2018 - 10/2015
2	Cryotherapy (Therapy, Cold) 01/2015 - 01/2014
1	Drug Tapering 01/2023
1	Endovascular Aneurysm Repair 10/2021
1	Adjuvant Radiotherapy 10/2015
1	Surgical Instruments (Clip) 01/2015
1	Electrocoagulation (Electrocautery) 01/2011
1	Conscious Sedation 07/2010
1	Length of Stay 09/2008